1. Home
  2. PBHC vs ATYR Comparison

PBHC vs ATYR Comparison

Compare PBHC & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBHC
  • ATYR
  • Stock Information
  • Founded
  • PBHC 1859
  • ATYR 2005
  • Country
  • PBHC United States
  • ATYR United States
  • Employees
  • PBHC N/A
  • ATYR N/A
  • Industry
  • PBHC Major Banks
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PBHC Finance
  • ATYR Health Care
  • Exchange
  • PBHC Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • PBHC 92.9M
  • ATYR 105.8M
  • IPO Year
  • PBHC N/A
  • ATYR 2015
  • Fundamental
  • Price
  • PBHC $15.14
  • ATYR $0.94
  • Analyst Decision
  • PBHC
  • ATYR Buy
  • Analyst Count
  • PBHC 0
  • ATYR 6
  • Target Price
  • PBHC N/A
  • ATYR $8.88
  • AVG Volume (30 Days)
  • PBHC 6.2K
  • ATYR 7.8M
  • Earning Date
  • PBHC 10-31-2025
  • ATYR 11-11-2025
  • Dividend Yield
  • PBHC 2.64%
  • ATYR N/A
  • EPS Growth
  • PBHC N/A
  • ATYR N/A
  • EPS
  • PBHC 0.28
  • ATYR N/A
  • Revenue
  • PBHC $39,015,000.00
  • ATYR N/A
  • Revenue This Year
  • PBHC N/A
  • ATYR $420.85
  • Revenue Next Year
  • PBHC N/A
  • ATYR $1,513.40
  • P/E Ratio
  • PBHC $53.94
  • ATYR N/A
  • Revenue Growth
  • PBHC N/A
  • ATYR N/A
  • 52 Week Low
  • PBHC $13.55
  • ATYR $0.68
  • 52 Week High
  • PBHC $18.53
  • ATYR $7.29
  • Technical
  • Relative Strength Index (RSI)
  • PBHC 50.29
  • ATYR 31.69
  • Support Level
  • PBHC $14.65
  • ATYR $0.94
  • Resistance Level
  • PBHC $15.20
  • ATYR $1.02
  • Average True Range (ATR)
  • PBHC 0.18
  • ATYR 0.07
  • MACD
  • PBHC -0.04
  • ATYR 0.11
  • Stochastic Oscillator
  • PBHC 82.44
  • ATYR 28.05

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: